ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Synaptic Mitochondrial Pathology in Alzheimer’s Disease
dc.contributor.author | Du, Heng | |
dc.contributor.author | Guo, Lan | |
dc.contributor.author | Yan, Shirley ShiDu | |
dc.date.accessioned | 2014-07-22T14:56:13Z | |
dc.date.available | 2014-07-22T14:56:13Z | |
dc.date.issued | 2012-06-15 | |
dc.identifier.citation | Du, Heng et al. (2012). Synaptic Mitochondrial Pathology in Alzheimer’s Disease. Antioxidants and Redox Signaling 16(12):147-75. http://www.dx.doi.org/10.1089/ars.2011.4277 | |
dc.identifier.issn | 1523-0864 | |
dc.identifier.uri | http://hdl.handle.net/1808/14809 | |
dc.description | This is the publisher's version, also available electronically from http://online.liebertpub.com/doi/abs/10.1089/ars.2011.4277. | |
dc.description.abstract | Significance: Synaptic degeneration, an early pathological feature in Alzheimer's disease (AD), is closely correlated to impaired cognitive function and memory loss. Recent studies suggest that involvement of amyloid-beta peptide (Aβ) in synaptic mitochondrial alteration underlies these synaptic lesions. Thus, to understand the Aβ-associated synaptic mitochondrial perturbations would fortify our understanding of synaptic stress in the pathogenesis of AD. Recent Advances: Increasing evidence suggests that synaptic mitochondrial dysfunction is strongly associated with synaptic failure in many neurodegenerative diseases including AD. Based on recent findings in human AD subjects, AD animal models, and AD cellular models, synaptic mitochondria undergo multiple malfunctions including Aβ accumulation, increased oxidative stress, decreased respiration, and compromised calcium handling capacity, all of which occur earlier than changes seen in nonsynaptic mitochondria before predominant AD pathology. Of note, the impact of Aβ on mitochondrial motility and dynamics exacerbates synaptic mitochondrial alterations. Critical Issues: Synaptic mitochondria demonstrate early deficits in AD; in combination with the role that synaptic mitochondria play in sustaining synaptic functions, deficits in synaptic mitochondria may be a key factor involved in an early synaptic pathology in AD. Future Directions: The importance of synaptic mitochondria in supporting synapses and the high vulnerability of synaptic mitochondria to Aβ make them a promising target of new therapeutic strategy for AD. Antioxid. Redox Signal. 16, 1467–1475. | |
dc.publisher | Mary Ann Liebert, Inc. | |
dc.title | Synaptic Mitochondrial Pathology in Alzheimer’s Disease | |
dc.type | Article | |
kusw.kuauthor | Yan, Shirley ShiDu | |
kusw.kudepartment | Pharmacology and Toxicology | |
kusw.oastatus | fullparticipation | |
dc.identifier.doi | 10.1089/ars.2011.4277 | |
kusw.oaversion | Scholarly/refereed, publisher version | |
kusw.oapolicy | This item meets KU Open Access policy criteria. | |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Scholarly Works [299]